30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Positions

Position Company Period
Chairman of the Board Sophiris Bio Inc Jan. 1, 2014 -
Independent Chairman of the Board Prothena Corporation PLC Dec. 1, 2012 -
Independent Chairman of the Board Amarin Corporation PLC Jan. 1, 2014 -
Independent Director Spark Therapeutics Inc May 1, 2014 -
Independent Director Ultragenyx Pharmaceutical Inc March 17, 2016 -
Lead Independent Director InterMune Inc May 13, 2008 -
Independent Director Ocera Therapeutics Inc July 15, 2013 - June 18, 2015
Executive Chairman of the Board Sophiris Bio Inc Oct. 1, 2012 - Jan. 1, 2014
Lead Independent Non-Executive Director Amarin Corporation PLC Oct. 20, 2011 - Jan. 1, 2014
Executive Chairman of the Board, President Sophiris Bio Inc April 18, 2011 - Aug. 1, 2012

Lars Ekman's trades of Prothena Corporation PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-01-05 2023-01-03 PlS Planned sale
57,121 -4.6%
98.72
US$528,471
57,121 -4.6% 98.72 US$528,471
2023-01-05 2023-01-03 PlS Planned sale
40,149 -20.7%
108.04
US$2,547,993
40,149 -20.7% 108.04 US$2,547,993
2023-01-05 2023-01-03 PlS Planned sale
83,081 -46.5%
216.29
US$4,675,531
83,081 -46.5% 216.29 US$4,675,531
2023-01-05 2023-01-03 PlS Planned sale
1,303 -41.4%
56.98
US$74,244
1,303 -41.4% 56.98 US$74,244
2023-01-05 2023-01-03 PlS Planned sale
6,621 -67.8%
56.33
US$372,970
6,621 -67.8% 56.33 US$372,970
2023-01-05 2023-01-03 PlS Planned sale
2,897 -22.9%
55.35
US$160,341
2,897 -22.9% 55.35 US$160,341
2023-01-05 2023-01-03 PlS Planned sale
3,411 -21.2%
54.15
US$184,707
3,411 -21.2% 54.15 US$184,707
2022-12-02 2022-12-01 PlS Planned sale
6,021 -96.1%
62.12
US$374,018
6,021 -96.1% 62.12 US$374,018
2022-12-02 2022-12-01 PlS Planned sale
9,813 -61.0%
61.28
US$601,388
9,813 -61.0% 61.28 US$601,388
2022-11-03 2022-11-01 PlS Planned sale
1,661 -87.2%
64.94
US$107,868
1,661 -87.2% 64.94 US$107,868
2022-11-03 2022-11-01 PlS Planned sale
3,312 -63.5%
64.26
US$212,824
3,312 -63.5% 64.26 US$212,824
2022-11-03 2022-11-01 PlS Planned sale
1,717 -24.8%
62.91
US$108,013
1,717 -24.8% 62.91 US$108,013
2022-11-03 2022-11-01 PlS Planned sale
9,143 -56.9%
62.01
US$566,953
9,143 -56.9% 62.01 US$566,953
2022-10-05 2022-10-03 PlS Planned sale
1,693 -87.4%
62.96
US$106,593
1,693 -87.4% 62.96 US$106,593
2022-10-05 2022-10-03 PlS Planned sale
6,355 -76.6%
62.11
US$394,677
6,355 -76.6% 62.11 US$394,677
2022-10-05 2022-10-03 PlS Planned sale
4,277 -34.0%
61.07
US$261,208
4,277 -34.0% 61.07 US$261,208
2022-10-05 2022-10-03 PlS Planned sale
3,508 -21.8%
60.32
US$211,604
3,508 -21.8% 60.32 US$211,604
2019-11-07 2019-11-05 PlS Planned sale
6,400 -100.0%
18.00
US$115,230
6,400 -100.0% 18.00 US$115,230
2019-09-05 2019-09-03 PlS Planned sale
91,016 -100.0%
15.01
US$1,365,722
91,016 -100.0% 15.01 US$1,365,722
2019-03-06 2019-03-04 PlS Planned sale
36,700 -100.0%
21.71
US$796,830
36,700 -100.0% 21.71 US$796,830
2019-03-06 2019-03-04 PlS Planned sale
98,677 -72.9%
21.16
US$2,088,074
98,677 -72.9% 21.16 US$2,088,074
2019-01-11 2019-01-10 PlS Planned sale
7,496 -100.0%
18.62
US$139,603
7,496 -100.0% 18.62 US$139,603
2019-01-11 2019-01-10 PlS Planned sale
55,762 -88.2%
18.16
US$1,012,671
55,762 -88.2% 18.16 US$1,012,671
2019-01-11 2019-01-10 PlS Planned sale
48,711 -43.5%
17.29
US$842,140
48,711 -43.5% 17.29 US$842,140
2019-01-11 2019-01-10 PlS Planned sale
7,247 -6.1%
15.96
US$115,678
7,247 -6.1% 15.96 US$115,678
2019-01-11 2019-01-10 PlS Planned sale
21,200 -15.1%
14.92
US$316,397
21,200 -15.1% 14.92 US$316,397